What Researchers Did
Researchers retrospectively studied 84 osteoradionecrosis patients in Thailand who received adjunctive hyperbaric oxygen therapy before surgery to determine its benefits for wound healing.
What They Found
Among 84 osteoradionecrosis patients (mean age 58.78 years; 54.76% male), hyperbaric oxygen therapy significantly improved wound healing for those with stages 1 and 2 of the condition. The study found a negative correlation between stage 3 ORN and the number of HBOT dives, suggesting less benefit for advanced cases.
What This Means for Canadian Patients
Canadian patients with early-stage osteoradionecrosis might consider adjunctive hyperbaric oxygen therapy as a potential treatment to improve wound healing. However, its effectiveness appears limited for more advanced stages of the condition, suggesting it may not be a universal solution.
Canadian Relevance
This study was conducted in Thailand and has no direct Canadian connection.
Study Limitations
As a retrospective study, it is limited by potential biases and the inability to establish a definitive cause-and-effect relationship for hyperbaric oxygen therapy's efficacy.